Floriana Morgillo

21PUBLICATIONS
117CO-AUTHORS
Molecular targetsGene and molecular therapyOncology and carcinogenesis not elsewhere classifiedLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 28, 2026
RAS Inhibitors: Changing the Paradigm from the Undruggable.

|Jul 02, 2026
RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. J. Pers. Med. 2022, 12, 1993.

|Jun 12, 2026
When Lymph Nodes Don't Lie: Report of Three Unusual Presentations of Thoracic Tumors.

|May 04, 2026
The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability.

|Mar 13, 2026
High prevalence of loss of Claudin-18 expression in invasive non-mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice.

Stefano Lucà, Marco Montella, Mario Fordellone

|Feb 13, 2026
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.

Antonello Veccia, Ettore D'Argento, Floriana Morgillo

Pageof 4

Frequent Collaborators

6 joint publications

Caterina De Rosa

5 joint publications

Francesca Iommelli

5 joint publications

Alfonso Fiorelli

5 joint publications

Luisa Amato